I added 7 shares of JNJ at $101.56 per share.
- JNJ is a global powerhouse. Over 1 billion people use JNJ products on a daily basis. Johnson & Johnson has a variety of products, which includes consumer health products, medical devices and diagnostics. Johnson & Johnson is also involved with pharmaceuticals which range from key areas like immunology, infectious diseases, neuroscience and oncology.
- Johnson & Johnson has a key focus on Innovation. JNJ spent approximately $7.7 billion for research and development and so far it's been a great investment. There has been strong sales from products like Simponi, Stelara and Zytiga.
- They have also been aggressive with acquisitions and building their brand.
- The dividend for JNJ stock currently yields an attractive 2.77%. JNJ management has increased the dividend payout for an impressive 51 years. Earnings for JNJ stock have increased for 30 straight years. Another plus is the company boasts a AAA credit rating. There is not doubt in my mind that JNJ will continue increasing it's dividend for years to come.